CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

    
  FY 2022 FY 2023 FY 2024 FY 2025 FY 2026(Est.)
Net Sales 12,326 12,585 13,030 13,617 13,960

Cost of Sales
(% of Net Sales)

6,931
56.2%
7,107
56.5%
7,326
56.2%
7,623
56.0%
7,747
55.5%

Gross Profit
(% of Net Sales)

5,395
43.8%
5,478
43.5%
5,704
43.8%
5,993
44.0%
6,212
44.5%

SG&A expenses
(% of Net Sales)

4,654
37.8%
4,675
37.1%
5,011
38.5%
4,988
36.6%
5,152
36.9%

Operating Income 
(% of Net Sales)

741
6.0%
803
6.4%
692
5.3%
1,005
7.4%
1,060
7.6%

Ordinary Income 
(% of Net Sales)

834
6.8%
872
6.9%
750
5.8%
988
7.3%
1,070
7.7%

Net Income
(% of Net Sales)

482
3.9%
154
1.2%
840
6.5%
713
5.2%
750
5.4%

Net Sales by Sales Format(cons.)

Unit:million yen

 
  FY 2022 FY 2023 FY 2024 FY 2025 FY 2026(Est.)

Own-brand
(%)

6,986
56.7%
6,920
55.0%
7,182
55.1%
7,734
56.8%
7,860
56.3%
Overseas
(%)
4,000
32.5%
4,257
33.8%
4,608
35.4%
4,598
33.8%
4,600
33.0%
OEM Sales
(%)
1,340
10.9%
1,407
11.2%
1,239
9.5%
1,284
9.4%
1,500
10.7%
Total
(%)
12,326
100.0%
12,585
100.0%
13,030
100.0%
13,617
100.0%
13,960
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2022 FY 2023 FY 2024 FY 2025 FY 2026(Est.)

Current Assets

12,128 12,722 13,940 14,222 14,618

Fixed Assets

6,736 6,535 6,107 5,920 5,859

Total Assets
(Gross Assets)

18,865 19,258 20,047 20,143 20,477

Current Liabilities

2,816 2,967 3,105 2,023 2,129

Fixed Liabilities

1,325 1,347 1,191 1,787 1,866

Total Liabilities

4,141 4,314 4,296 3,810 3,995

Shareholders' Equity

14,723 14,944 15,750 16,332 16,482

Equity Ratio

78.0% 77.6% 78.6% 81.1% 80.5%

Cash Flow Data

Unit:million yen

  FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
(Est.)

Net cash provided by (used in) operating activities

478 698 2,249 530 1,059

Net cash provided by (used in) investing activities

43 △ 363 270 △ 573 △ 492

Net cash provided by (used in) financing activities

△ 356 △ 362 △ 877 △ 600 △ 336

Net increase in cash and cash equivalents

288 68 1,891 △ 601 231

Cash and cash equivalents at end of year

3,702 3,770 5,662 5,060 5,338

Free Cash Flow

522 335 2,520 △ 42 567
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2022 FY 2023 FY 2024 FY 2025 FY 2026(Est.)
ROE 3.3% 1.0% 5.5% 4.4% 4.6%
EPS(yen) 53.00 16.92 95.41 84.25 89.44
BPS(yen) 1,618.10 1,641.59 1,833.67 1,947.68 1,965.53

Dividend per Share (yen)

37 37 39 45 47

Dividend Payout Ratio(cons.)

69.8% 218.7% 40.9% 53.4% 52.5%

TOP